On January 25, 2026, Yicheng City held the municipal Economic Work Conference and Three-level Cadres Conference. The commending ceremony recognized advanced collectives and individuals who made outstanding contributions to the city’s economic and social development in 2025.Hubei Tianshu Pharmaceutical Co., Ltd. (Tianshu Pharmaceutical) was awarded the honorary title of "Advanced Collective for County Economic Development 2025" for its outstanding performance and remarkable contributions in industrial upgrading, R&D innovation and county empowerment, standing as a backbone force driving economic growth in Yicheng’s biomedical industry. Liu Yunlong, General Manager of Tianshu Pharmaceutical, attended the conference as the enterprise representative and received the award on stage.
As a key local enterprise rooted in Yicheng, Tianshu Pharmaceutical has always upheld its corporate mission of "Empowering Global Customers with Differentiated Technologies", shouldering corporate responsibilities with down-to-earth efforts and driving industrial upgrading through scientific and technological innovation.In recent years, the company has further optimized its core industrial layout covering innovative drug CDMO, high-end APIs and advanced pharmaceutical intermediates. It not only provides professional empowerment for global customers and supports partners’ high-quality development, but also effectively gathers momentum for the development of the regional biomedical industry and stimulates the coordinated vitality of the industrial upstream and downstream chains.Continuously making efforts in stabilizing economic growth, promoting employment and advancing industrial development, Tianshu Pharmaceutical, with a sound market reputation and rising industry influence, has injected strong impetus into the high-quality economic development of Yicheng County, vividly interpreting the responsibilities and commitments of private enterprises as the backbone of the market economy.
Since putting into production, Tianshu Pharmaceutical has maintained robust growth with year-on-year rising output value. It achieved an output value of nearly 100 million yuan in the first year of production, which climbed to nearly 400 million yuan in 2025. Boasting strong comprehensive strength, the company has been successfully selected into the Top 20 Chinese Pharmaceutical CDMO Enterprises, gaining authoritative recognition for its industry status.The rapid development of the enterprise has brought remarkable industrial empowerment and economic benefits to Yicheng, creating more than 300 jobs.Meanwhile, Tianshu Pharmaceutical and its headquarters Nanjing Weikirui have built a dual-city collaborative model of "R&D in Nanjing, Production in Yicheng", which has revitalized local production capacity, attracted investment from superior industrial funds, driven the continuous expansion of high-end API projects, and formed a chain reaction of rescuing one enterprise, reshaping one industry and activating one industrial chain, continuously injecting new momentum into the high-quality economic development of Yicheng County.
The honor is not only recognition, but also a clarion call for forging ahead. Standing at the new starting point of the 15th Five-Year Plan, Tianshu Pharmaceutical expresses sincere gratitude to the Yicheng Municipal Party Committee and Municipal Government for their targeted guidance and resource support, as well as the trust and collaboration from all sectors of society.Taking this honor as a new opportunity, the company will continuously improve operational efficiency, pursue high-quality development with higher standards and more practical measures, and contribute "Tianshu Strength" to building Yicheng into a trillion-yuan output city, a top-50 competitive city and a happy city.
